Efficiency analysis of multiple sclerosis therapies

Description

In this project, various questions regarding the efficacy of approved multiple sclerosis (MS) therapies were analyzed. This included descriptive analyses of various medical metrics, as well as time-to-event models corrected for real-world biases. The analysis is based on the real-world data of a large German physicians’ network in the field of neurology.